Summary

Chapter 1: Introduction to Drug Safety in Cardiology

2

1.1 Overview of Cardiovascular Medication Risks

2

1.2 The Importance of Monitoring for Adverse Drug Reactions

4

1.3 Strategies for Enhancing Patient Safety

6

Chapter 2: Antiarrhythmic Drugs and Their Management

8

2.1 Understanding Antiarrhythmics and Proarrhythmia

8

2.2 Monitoring Electrolytes and ECGs in Antiarrhythmic Therapy

10

2.3 Case Studies on Antiarrhythmic Drug Safety

12

Chapter 3: Anticoagulants in Cardiology Practice

14

3.1 Role and Risks of Anticoagulants in Preventing Blood Clots

14

3.2 Dose Adjustments and Renal Function Considerations

16

3.3 Coagulation Parameters Monitoring for Safe Use

18

Chapter 4: Managing Heart Failure Medications Safely

20

4.1 ACE Inhibitors and Beta-Blockers: Benefits vs Risks

20

4.2 Dosing Considerations and Patient Monitoring

22

4.3 Addressing Polypharmacy and Drug-Drug Interactions

24

Chapter 5: Multidisciplinary Approach to Drug Safety in Cardiology

26

5.1 Roles of Healthcare Providers, Pharmacists, and Patients

26

5.2 Implementing Team-Based Care Models for Effective Management

28

5.3 Utilizing Technology for Improved Drug Safety Monitoring

30

Chapter 6: Drug Interactions in Cardiology

32

6.1 Understanding Drug-Drug Interactions in Cardiovascular Medications

32

6.2 Common Drug Interactions and Their Potential Consequences

34

6.3 Strategies for Preventing and Managing Drug Interactions in Cardiology

36

Drug safety in cardiology